-
Broad SARS-CoV-2 neutralization by monoclonal and bispecific antibodies derived from a Gamma-infected individual
Guerra, D., Beaumont, T., Radić, L., Kerster, G., van der Straten, K., Yuan, M., Torres, J. L., Lee, W-H., Liu, H., Poniman, M., Bontjer, I., Burger, J. A., Claireaux, M., Caniels, T. G., Snitselaar, J. L., Bijl, T. P. L., Kruijer, S., Ozorowski, G., Gideonse, D., Sliepen, K., & 6 others , 20 Oct 2023, In: iScience. 26, 10, 108009.Research output: Contribution to journal › Article › Academic › peer-review
-
Fourth mRNA COVID-19 vaccination in immunocompromised patients with haematological malignancies (COBRA KAI): a cohort study
COBRA KAI Study Team, 1 Jul 2023, In: EClinicalMedicine. 61, 102040.Research output: Contribution to journal › Article › Academic › peer-review
-
Antibody Response in Immunocompromised Patients With Hematologic Cancers Who Received a 3-Dose mRNA-1273 Vaccination Schedule for COVID-19
COBRA KAI Study Team, 1 Oct 2022, In: JAMA Oncology. 8, 10, p. 1477-1483 7 p.Research output: Contribution to journal › Article › Academic › peer-review
- All publications